Greg Fitzgibbon

Greg is a Clinical Laboratory Director with the New York State Department of Health Certificate of Qualification and provides the clinical expertise required for Metabolomic Diagnostics expanding business and product portfolio. Greg has previously been the COO and Clinical Affairs Director of multiple Molecular Diagnostic Companies. He has led operations teams in performing product development for In Vitro Diagnostic (IVD) products under ISO 13485 quality management systems with a focus on women's health and prenatal testing portfolios. Greg holds a Doctorate in Molecular Genetics, he is an HCPC registered Clinical Scientist and a Diplomate member of the Royal College of Pathologists. Greg has over 8 years of management experience within the NHS. He has also had over 8 years of involvement with the inception, growth, and development of Biotechnology businesses including Syngenta, Gen-Probe, Hologic, Epistem, Elucigene Diagnostics, Your gene Health, and MyHealthChecked, on top of validating technologies for corporate giants including GSK and Government Institutions.